Stay updated with breaking news from Nasdaq Cbay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) insider Charles Mcwherter sold 11,332 shares of the firm’s stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $21.48, for a total value of $243,411.36. Following the sale, the insider now directly owns 15,000 shares in the company, valued […]
CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) General Counsel Paul T. Quinlan sold 5,000 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $21.98, for a total transaction of $109,900.00. The transaction was disclosed in a legal filing with the SEC, […]
CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) General Counsel Paul T. Quinlan sold 5,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $17.38, for a total transaction of $86,900.00. The transaction was disclosed in a filing with the SEC, which […]
CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) General Counsel Paul T. Quinlan sold 5,000 shares of CymaBay Therapeutics stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $17.38, for a total value of $86,900.00. The transaction was disclosed in a legal filing with the Securities & […]
CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) insider Charles Mcwherter sold 11,342 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $18.28, for a total value of $207,331.76. Following the sale, the insider now directly owns 15,000 shares of the company’s […]